Drug application
E.E.S. 200 (ERYTHROMYCIN ETHYLSUCCINATE)
Drugs@FDA ANDA 061639 · ARBOR PHARMS LLC
Key facts
| Drug name | E.E.S. 200 |
|---|---|
| Active ingredients | ERYTHROMYCIN ETHYLSUCCINATE |
| Application type | ANDA |
| Application number | 061639 |
| Company | ARBOR PHARMS LLC |
| Dosage forms | SUSPENSION, ORAL |
| Strength | EQ 200MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Oct 15, 1973 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: